You are here

Viral Inactivation Market Size, Share, Trends and Outlook 2031

Submitted by bomma on Sat, 12/13/2025 - 02:24

Precision Business Insights has published a report on the global viral inactivation market, estimating its value at USD 2.4 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 12.8% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/viral-inactivation-market

Viral inactivation is a bioprocessing technology that destroys or deactivates viruses in biological products using chemical, thermal, or physical means (for example, solvent-detergent treatment, low pH adjustment, UV irradiation, or pasteurization).

Drivers:

Growth in monoclonal antibodies, recombinant proteins, and cell/gene therapies increases the need for viral safety testing.
Rising cases of cancer, diabetes, and autoimmune disorders boost biopharmaceutical R&D, indirectly expanding viral inactivation needs.
The global viral inactivation market segmentation:

1) By Product Type: Viral Inactivation Systems, Kits & Reagents, Accessories, and Services

2) By Method: Pasteurization, Solvent Detergents, and Others

3) By Application Type: Blood & Blood products, Tissue & Tissue Products, Vaccines and Therapeutic, Cellular & Gene Therapy Products, Stem Cell Products and Others

4) By End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Others

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=58787

Regional Overview:
The report also examines the current concerns and their Future Effects on the viral inactivation market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the viral inactivation market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

North America (U.S., Canada)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Parker Hannifin, Clean Cells, Charles River Laboratories International, Inc., Sartorius AG, Danaher Corporation, Merck KGaA, SGS S.A., Texcell, Inc., Viral Inactivated Plasma Systems SA, WuXi PharmaTech Inc., Rad Source Technologies

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747